ADVM

Adverum Biotechnologies, Inc. ADVM

ADVM
Adverum Biotechnologies, Inc. ARTV
Artiva Biotherapeutics, Inc. GUTS
Fractyl Health, Inc. Common Stock STRO
Sutro Biopharma, Inc. DTIL
Precision BioSciences, Inc. MGX
Metagenomi, Inc. Common Stock ALXO
ALX Oncology Holdings Inc. ATYR
aTyr Pharma, Inc. BMEA
Biomea Fusion, Inc. PLRX
Pliant Therapeutics, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ADVM ARTV GUTS STRO DTIL MGX ALXO ATYR BMEA PLRX
6M 77.24 % 66.67 % 8.98 % 22.53 % 2.24 % 15.73 % 188.84 % -85.19 % -40.25 % -10.87 %
YTD -9.17 % -66.90 % 5.40 % -49.27 % 6.82 % -56.33 % -5.13 % -80.30 % -61.79 % -90.74 %
1Y -17.11 % -68.27 % 6.40 % -52.71 % 5.70 % -46.78 % -3.90 % -74.58 % -75.90 % -91.03 %
3Y -30.90 % -72.50 % -82.53 % -86.95 % -86.42 % -83.95 % -86.81 % -55.48 % -80.74 % -93.59 %
5Y -96.89 % -72.50 % -82.53 % -95.49 % -97.92 % -83.95 % -98.15 % -55.48 % -91.71 % -95.51 %
10Y -94.78 % -72.50 % -82.53 % -93.56 % -99.04 % -83.95 % -95.07 % -55.48 % -91.71 % -94.23 %
From the beginning -98.44 % -72.50 % -82.53 % -93.56 % -99.04 % -83.95 % -95.07 % -55.48 % -91.71 % -94.23 %

Dividend